-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Initiates Coverage On Guardian Pharmacy Service with Outperform Rating, Announces Price Target of $30

Benzinga·10/10/2025 17:49:30
Listen to the news
Oppenheimer analyst Michael Wiederhorn initiates coverage on Guardian Pharmacy Service (NYSE:GRDN) with a Outperform rating and announces Price Target of $30.